PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

Title
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 21, Issue 9, Pages 2065-2074
Publisher
American Association for Cancer Research (AACR)
Online
2015-02-04
DOI
10.1158/1078-0432.ccr-14-2993

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started